Cargando…
The Effect of Antihypertensive Drugs on NADH in Newly Diagnosed Primary Hypertension
BACKGROUND: Some antihypertensive medications alter cellular energy production, presumably by modification of the mitochondrial function. In vivo studies of such effects are challenging in humans. We applied a noninvasive forearm skin measurement of the 460-nm fluorescence specific for the reduced f...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989586/ https://www.ncbi.nlm.nih.gov/pubmed/35402043 http://dx.doi.org/10.1155/2022/6159883 |
_version_ | 1784683209104031744 |
---|---|
author | Pawlak-Chomicka, Regina Krauze, Tomasz Uruski, Pawel Piskorski, Jaroslaw Wykretowicz, Andrzej Tykarski, Andrzej Guzik, Przemyslaw |
author_facet | Pawlak-Chomicka, Regina Krauze, Tomasz Uruski, Pawel Piskorski, Jaroslaw Wykretowicz, Andrzej Tykarski, Andrzej Guzik, Przemyslaw |
author_sort | Pawlak-Chomicka, Regina |
collection | PubMed |
description | BACKGROUND: Some antihypertensive medications alter cellular energy production, presumably by modification of the mitochondrial function. In vivo studies of such effects are challenging in humans. We applied a noninvasive forearm skin measurement of the 460-nm fluorescence specific for the reduced form of nicotinamide adenine dinucleotide (NADH) to study the 6-week effects of four different antihypertensive medications on mitochondrial function using the Flow-Mediated Skin Fluorescence (FMSF). METHODS: In a prospective open-label study, we compared the long-term effects of a 6-week treatment with either amlodipine (5 mg), perindopril (5 mg), nebivolol (5 mg), or metoprolol (50 mg) on the dynamic flow-mediated changes in the skin NADH content in 76 patients (29 women) with untreated primary arterial hypertension (HA). Patients underwent 24-hour ambulatory blood pressure monitoring. To study mitochondrial function, the FMSF was measured at rest, during 100-second ischemia and postischemic reperfusion. The control group consisted of 18 healthy people (7 women). RESULTS: There were no significant differences in the FMSF parameters between the control and the study group before medication. After the 6-week treatment, all drugs similarly reduced blood pressure. Neither amlodipine, perindopril, nor nebivolol changed the flow-mediated 460-nm skin fluorescence significantly. However, metoprolol raised this fluorescence at rest, during ischemia and reperfusion (P at most <0.05), indicating an increase in the total NADH skin content. CONCLUSION: Amlodipine, perindopril, and nebivolol appear neutral for the skin NADH content during the 6-week antihypertensive treatment. Similar treatment with metoprolol increased skin NADH at rest, during ischemia and reperfusion, probably due to an effect on microcirculation and altered mitochondrial function. Explanation of the potential mechanisms behind metoprolol influence on the skin NADH metabolism requires further investigation. |
format | Online Article Text |
id | pubmed-8989586 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-89895862022-04-08 The Effect of Antihypertensive Drugs on NADH in Newly Diagnosed Primary Hypertension Pawlak-Chomicka, Regina Krauze, Tomasz Uruski, Pawel Piskorski, Jaroslaw Wykretowicz, Andrzej Tykarski, Andrzej Guzik, Przemyslaw Cardiol Res Pract Research Article BACKGROUND: Some antihypertensive medications alter cellular energy production, presumably by modification of the mitochondrial function. In vivo studies of such effects are challenging in humans. We applied a noninvasive forearm skin measurement of the 460-nm fluorescence specific for the reduced form of nicotinamide adenine dinucleotide (NADH) to study the 6-week effects of four different antihypertensive medications on mitochondrial function using the Flow-Mediated Skin Fluorescence (FMSF). METHODS: In a prospective open-label study, we compared the long-term effects of a 6-week treatment with either amlodipine (5 mg), perindopril (5 mg), nebivolol (5 mg), or metoprolol (50 mg) on the dynamic flow-mediated changes in the skin NADH content in 76 patients (29 women) with untreated primary arterial hypertension (HA). Patients underwent 24-hour ambulatory blood pressure monitoring. To study mitochondrial function, the FMSF was measured at rest, during 100-second ischemia and postischemic reperfusion. The control group consisted of 18 healthy people (7 women). RESULTS: There were no significant differences in the FMSF parameters between the control and the study group before medication. After the 6-week treatment, all drugs similarly reduced blood pressure. Neither amlodipine, perindopril, nor nebivolol changed the flow-mediated 460-nm skin fluorescence significantly. However, metoprolol raised this fluorescence at rest, during ischemia and reperfusion (P at most <0.05), indicating an increase in the total NADH skin content. CONCLUSION: Amlodipine, perindopril, and nebivolol appear neutral for the skin NADH content during the 6-week antihypertensive treatment. Similar treatment with metoprolol increased skin NADH at rest, during ischemia and reperfusion, probably due to an effect on microcirculation and altered mitochondrial function. Explanation of the potential mechanisms behind metoprolol influence on the skin NADH metabolism requires further investigation. Hindawi 2022-03-31 /pmc/articles/PMC8989586/ /pubmed/35402043 http://dx.doi.org/10.1155/2022/6159883 Text en Copyright © 2022 Regina Pawlak-Chomicka et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Pawlak-Chomicka, Regina Krauze, Tomasz Uruski, Pawel Piskorski, Jaroslaw Wykretowicz, Andrzej Tykarski, Andrzej Guzik, Przemyslaw The Effect of Antihypertensive Drugs on NADH in Newly Diagnosed Primary Hypertension |
title | The Effect of Antihypertensive Drugs on NADH in Newly Diagnosed Primary Hypertension |
title_full | The Effect of Antihypertensive Drugs on NADH in Newly Diagnosed Primary Hypertension |
title_fullStr | The Effect of Antihypertensive Drugs on NADH in Newly Diagnosed Primary Hypertension |
title_full_unstemmed | The Effect of Antihypertensive Drugs on NADH in Newly Diagnosed Primary Hypertension |
title_short | The Effect of Antihypertensive Drugs on NADH in Newly Diagnosed Primary Hypertension |
title_sort | effect of antihypertensive drugs on nadh in newly diagnosed primary hypertension |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989586/ https://www.ncbi.nlm.nih.gov/pubmed/35402043 http://dx.doi.org/10.1155/2022/6159883 |
work_keys_str_mv | AT pawlakchomickaregina theeffectofantihypertensivedrugsonnadhinnewlydiagnosedprimaryhypertension AT krauzetomasz theeffectofantihypertensivedrugsonnadhinnewlydiagnosedprimaryhypertension AT uruskipawel theeffectofantihypertensivedrugsonnadhinnewlydiagnosedprimaryhypertension AT piskorskijaroslaw theeffectofantihypertensivedrugsonnadhinnewlydiagnosedprimaryhypertension AT wykretowiczandrzej theeffectofantihypertensivedrugsonnadhinnewlydiagnosedprimaryhypertension AT tykarskiandrzej theeffectofantihypertensivedrugsonnadhinnewlydiagnosedprimaryhypertension AT guzikprzemyslaw theeffectofantihypertensivedrugsonnadhinnewlydiagnosedprimaryhypertension AT pawlakchomickaregina effectofantihypertensivedrugsonnadhinnewlydiagnosedprimaryhypertension AT krauzetomasz effectofantihypertensivedrugsonnadhinnewlydiagnosedprimaryhypertension AT uruskipawel effectofantihypertensivedrugsonnadhinnewlydiagnosedprimaryhypertension AT piskorskijaroslaw effectofantihypertensivedrugsonnadhinnewlydiagnosedprimaryhypertension AT wykretowiczandrzej effectofantihypertensivedrugsonnadhinnewlydiagnosedprimaryhypertension AT tykarskiandrzej effectofantihypertensivedrugsonnadhinnewlydiagnosedprimaryhypertension AT guzikprzemyslaw effectofantihypertensivedrugsonnadhinnewlydiagnosedprimaryhypertension |